2019 New York Laws
PBH - Public Health
Article 33-A - Controlled Substances Therapeutic Research Act
3397-E - Patient Participation in Program; Procedure.
§ 3397-e. Patient participation in program; procedure. 1. Any hospital may establish a hospital patient qualification review committee subject to the rules and regulations promulgated by the commissioner. A hospital may designate a hospital human research review committee as set forth in section twenty-four hundred forty-four of this chapter to serve as a hospital patient qualification review committee.
2. Any physician may recommend a patient for participation in the Antonio G. Olivieri controlled substances therapeutic research program to the hospital patient qualification review committee for the hospital wherein such patient has received medical treatment.
3. The hospital patient qualification review committee shall review each recommendation and shall submit approved patient applications to the state patient qualification review board.
4. The state patient qualification review board shall review all physician applicants for the Antonio G. Olivieri controlled substances therapeutic research program and certify or refuse to certify their participation in the program.
5. The state patient qualification review board may delegate to a hospital patient qualification review committee the authority to approve or disapprove a patient's participation in such program.
6. A patient shall not be eligible to participate in such program without the approval of the state patient qualification review board or the hospital patient qualification review committee delegated pursuant to subdivision five of this section.
7. The hospital human research review committee shall review each human research project proposed hereunder and shall certify to the hospital patient qualification review committee that such project meets the requirements of this article and article twenty-four-A of this chapter.
